Kilambi News
Friday, November 20, 2026

Archive

Every story, newest first.

Sunday, November 8, 2026

Infrastructure

Revolution Wind reaches full commercial operations at 704 megawatts

The 704 megawatt Revolution Wind farm off Rhode Island reached full commercial operations in October, Orsted confirmed on November 5, delivering under 20 year contracts to Rhode Island and Connecticut.

Infrastructure

Jakarta targets PAM Jaya water utility IPO in 2027

Jakarta Governor Pramono Anung said on November 8 he will allow city water utility PAM Jaya to hold an initial public offering in 2027 if market conditions are favourable, with preparations about 93 percent complete.

Infrastructure

Infra deals also notable: Ryder acquisition, Gabon rare earths seek

Ryder System has acquired East Coast fleet operator Efficiency Enterprises, adding about 1,200 vehicles and about 50 million dollars in expected gross revenue, while Gabon is reported to be seeking 2 billion dollars to revive the Mabounie rare earths project.

Infrastructure

Hapag-Lloyd completes 25 percent stake in Maasvlakte II terminal

Hapag-Lloyd has completed its acquisition of a 25 percent stake in APM Terminals Maasvlakte II in Rotterdam after unconditional antitrust approval, with financial terms undisclosed.

Infrastructure

Brookfield raises 25 billion dollars in third quarter

Brookfield Asset Management raised 25 billion dollars in the third quarter, taking fundraising for the first nine months of 2026 to 123 billion dollars, its November 6 results showed.

Infrastructure

Avantus upsizes corporate credit facility to 1.28 billion dollars

Avantus has upsized its corporate credit facility to 1.28 billion dollars from 1.05 billion dollars, adding five new lead arrangers to support its solar and storage pipeline.

Life Sciences

Intensive blood pressure control helps after stroke, not diabetes

Two Brazilian trials published in the New England Journal of Medicine found a systolic target below 120 mm Hg cut major cardiovascular events after stroke (10.9 against 13.5 percent) but did not significantly reduce events in type 2 diabetes (6.0 against 6.7 percent).

Life Sciences

Cloudbreak eye drop meets Phase 3 endpoints in pterygium

Cloudbreak Pharma's CBT-001 eye drop met both primary endpoints in its 659 patient Phase 3 trial in pterygium, improving eye redness at three months and preventing lesion growth at 12 months, both at p below 0.001.

Life Sciences

BIO sues to block Medicare GLOBE international pricing model

The Biotechnology Innovation Organization, Biocom California and the California Life Sciences Association sued on November 6 in federal court in California to halt the GLOBE model, which would rebate Medicare Part B drug prices down toward government set prices in 19 other countries.

Life Sciences

Also notable in life sciences on November 8

Early spironolactone after stroke helped patients reach blood pressure targets in a small AHA trial, a yoga based rehabilitation programme improved outcomes in heart failure in India, and EU veterinary regulators gave a first limited market authorisation.